Children’s Receives $20 Million from Peach Bowl, Inc. to Fight Childhood Cancer Gift will establish the Peach Bowl LegACy Fund Monday, Sept. 16, 2019 Gift will establish the Peach Bowl LegACy Fund...

Children’s Healthcare of Atlanta was recently selected as an OUtMATCH clinical trial site to test whether omalizumab, an FDA-approved treatment for asthma, could be effective at protecting patients with multiple food allergies.

A Children’s Healthcare of Atlanta patient has become the youngest patient to date to receive experimental convalescent plasma transfusions to treat the novel coronavirus.

IDG’s Insider Pro and Computerworld recognize Children’s in 2020 rankings

College Football Fans Donate $300,000+ Chick-fil-A Peach Bowl Touchdowns for Children's (T4C) campaign benefits pediatrics Wednesday, Dec. 19, 2018 Chick-fil-A Peach Bowl Touchdowns for Children's...

Introducing 'The Atlanta Protocol' New method to help treat pediatric patients with hemophilia A Wednesday, Aug. 28, 2019 New method to help treat pediatric patients with hemophilia A Wednesday, Aug....

A new study published today in the New England Journal of Medicine could lead to therapeutic treatment options for children and adolescents allergic to peanuts.

Crafting a Vaccine Against RSV Scientists believe they have found a way to craft an RSV vaccine Thursday, Dec. 22, 2016 Scientists believe they have found a way to craft an RSV vaccine Thursday, Dec....

Emory Department of Pediatrics, the primary academic partner of Children’s Healthcare of Atlanta, is the third largest recipient of federal pediatric research dollars from the National Institutes of Health (NIH), according to rankings from the Blue Ridge Institute for Medical Research.

Kids With CHD More Likely to Develop Autism Findings show kids with congenital heart disease 32% more likely to develop autism Wednesday, Nov. 13, 2019 Findings show kids with congenital heart...